Viridian Therapeutics Inc

XNAS: VRDN

Download real time

15.26 -0.06 (-0.39%)

43.90% Fall from 52W High

1.8M XNAS Volume

High volume today

XNAS 21 Mar, 2025 5:30 PM (EDT)

1,243.5

Market Cap

Below industry Median

0.0

Beta 1Year

Very Low volatility

Viridian Therapeutics Inc - VRDN - stock price prediction, stock price target, analyst ratings from 17 analysts

Viridian Therapeutics Inc has a share price target of US$ 40, revenue growth forecast of -46.7%, and profit growth estimate of -24.4% for FY25, based on top 17 analyst calls.

Forecaster Screeners